CD8A and cancer: It has beenshown that increased antigen-specific CD8+ T cell infiltrationinto tumors is often correlated with improved ICB response rates.This has fueled interest in therapeutic cancer vaccines that can activatean antitumor T cell response, thereby enhancing efficacy of ICB.